Cargando…

Cdc2-like kinases: structure, biological function, and therapeutic targets for diseases

The CLKs (Cdc2-like kinases) belong to the dual-specificity protein kinase family and play crucial roles in regulating transcript splicing via the phosphorylation of SR proteins (SRSF1–12), catalyzing spliceosome molecular machinery, and modulating the activities or expression of non-splicing protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Mengqiu, Pang, Luping, Zhang, Mengmeng, Qu, Yingzi, Laster, Kyle Vaughn, Dong, Zigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082069/ https://www.ncbi.nlm.nih.gov/pubmed/37029108 http://dx.doi.org/10.1038/s41392-023-01409-4

Ejemplares similares

Cdc-Like Kinases (CLKs): Biology, Chemical Probes, and Therapeutic Potential
por: Martín Moyano, Paula, et al.
Publicado: (2020)

Oxethazaine inhibits esophageal squamous cell carcinoma proliferation and metastasis by targeting aurora kinase A
por: Bao, Zhuo, et al.
Publicado: (2022)

The comparison of cancer gene mutation frequencies in Chinese and U.S. patient populations
por: Ma, Fayang, et al.
Publicado: (2022)

CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer
por: Uzor, Simon, et al.
Publicado: (2021)

Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
por: Yin, Fanxiang, et al.
Publicado: (2022)

3-Deoxysappanchalcone Inhibits Skin Cancer Proliferation by Regulating T-Lymphokine-Activated Killer Cell-Originated Protein Kinase in vitro and in vivo
por: Fu, Xiaorong, et al.
Publicado: (2021)

Structural Basis for the Selective Inhibition of Cdc2-Like Kinases by CX-4945
por: Lee, Joo Youn, et al.
Publicado: (2019)

Structural Basis for the Activation and Target Site Specificity of CDC7 Kinase
por: Dick, Samual D., et al.
Publicado: (2020)

Anwulignan is a novel JAK1 inhibitor that suppresses non‐small cell lung cancer growth
por: Xie, Xiaomeng, et al.
Publicado: (2021)

Arbidol inhibits human esophageal squamous cell carcinoma growth in vitro and in vivo through suppressing ataxia telangiectasia and Rad3-related protein kinase
por: Yang, Ning, et al.
Publicado: (2022)

Molecular structures of cdc2-like kinases in complex with a new inhibitor chemotype
por: Walter, Anne, et al.
Publicado: (2018)

Costunolide is a dual inhibitor of MEK1 and AKT1/2 that overcomes osimertinib resistance in lung cancer
por: Tian, Xueli, et al.
Publicado: (2022)

Ethyl Ferulate Suppresses Esophageal Squamous Cell Carcinoma Tumor Growth Through Inhibiting the mTOR Signaling Pathway
por: Pang, Mengjun, et al.
Publicado: (2022)

Therapeutic Targeting the Cell Division Cycle 25 (CDC25) Phosphatases in Human Acute Myeloid Leukemia — The Possibility to Target Several Kinases through Inhibition of the Various CDC25 Isoforms
por: Brenner, Annette K., et al.
Publicado: (2014)

Toosendanin targeting eEF2 impedes Topoisomerase I & II protein translation to suppress esophageal squamous cell carcinoma growth
por: Jia, Xuechao, et al.
Publicado: (2023)

PIM Kinase as an Executional Target in Cancer
por: Zhang, Xinning, et al.
Publicado: (2018)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
por: Shi, Xiaodan, et al.
Publicado: (2021)

Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview
por: Lindberg, Mattias F., et al.
Publicado: (2021)

PAR proteins direct asymmetry of the cell cycle regulators Polo-like kinase and Cdc25
por: Rivers, David M., et al.
Publicado: (2008)

CDC-like kinase 4 deficiency contributes to pathological cardiac hypertrophy by modulating NEXN phosphorylation
por: Huang, Jian, et al.
Publicado: (2022)

The structural basis of Cdc7-Dbf4 kinase dependent targeting and phosphorylation of the MCM2-7 double hexamer
por: Saleh, Almutasem, et al.
Publicado: (2022)

Drug design with Cdc7 kinase: a potential novel cancer therapy target
por: Sawa, Masaaki, et al.
Publicado: (2009)

Saccharomyces cerevisiae polo-like kinase, Cdc5 exhibits ATP-dependent Mg(2+)-enhanced kinase activity in vitro
por: Chauhan, Sujata, et al.
Publicado: (2019)

Cdc7 kinase stimulates Aurora B kinase in M-phase
por: Ito, Sayuri, et al.
Publicado: (2019)

2,6-DMBQ is a novel mTOR inhibitor that reduces gastric cancer growth in vitro and in vivo
por: Zu, Xueyin, et al.
Publicado: (2020)

Structural Insight into the MCM double hexamer activation by Dbf4-Cdc7 kinase
por: Cheng, Jiaxuan, et al.
Publicado: (2022)

mir-218-2 promotes glioblastomas growth, invasion and drug resistance by targeting CDC27
por: Feng, Zhuoying, et al.
Publicado: (2016)

Polo-like kinase 1 promotes Cdc42-induced actin polymerization for asymmetric division in oocytes
por: Yuen, Wai Shan, et al.
Publicado: (2023)

Inflammasome: structure, biological functions, and therapeutic targets
por: Dai, Yali, et al.
Publicado: (2023)

Methyltransferase-like proteins in cancer biology and potential therapeutic targeting
por: Qi, Ya-Nan, et al.
Publicado: (2023)

Hsp90-Dependent Activation of Protein Kinases Is Regulated by Chaperone-Targeted Dephosphorylation of Cdc37
por: Vaughan, Cara K., et al.
Publicado: (2008)

HSP90-CDC37-PP5 forms a structural platform for kinase dephosphorylation
por: Oberoi, Jasmeen, et al.
Publicado: (2022)

Structural Bioinformatics and Protein Docking Analysis of the Molecular Chaperone-Kinase Interactions: Towards Allosteric Inhibition of Protein Kinases by Targeting the Hsp90-Cdc37 Chaperone Machinery
por: Lawless, Nathan, et al.
Publicado: (2013)

Requirement for p34cdc2 kinase is restricted to mitosis in the mammalian cdc2 mutant FT210
Publicado: (1992)

Progress in the therapeutic inhibition of Cdc42 signalling
por: Murphy, Natasha P., et al.
Publicado: (2021)

CDC20 in and out of mitosis: a prognostic factor and therapeutic target in hematological malignancies
por: Bruno, Samantha, et al.
Publicado: (2022)

Identification of CDC25 as a Common Therapeutic Target for Triple-Negative Breast Cancer
por: Liu, Jeff C., et al.
Publicado: (2018)

Targeting integrin αvβ3 with indomethacin inhibits patient‐derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma
por: Liu, Fangfang, et al.
Publicado: (2021)

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer Treatment()
por: Liu, Xiaoqi
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_plk3tnm0g998j6rpop4qim5udi